Cargando…
S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism
BACKGROUND: Rheumatoid arthritis (RA) is a long-term autoimmune disorder characterized by chronic inflammation that results in swollen and painful joints and even cartilage and bone damage. The gut microbiota, a novel anti-inflammatory target, is considered an important environmental factor in the d...
Autores principales: | Wang, Zhou, Yu, Yue, Liao, Junyi, Hu, Wei, Bian, Xiqing, Wu, Jianlin, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378902/ https://www.ncbi.nlm.nih.gov/pubmed/34422677 http://dx.doi.org/10.3389/fcimb.2021.670593 |
Ejemplares similares
-
Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China
por: Sun, Yang, et al.
Publicado: (2019) -
S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway
por: Wu, Wei-Jun, et al.
Publicado: (2016) -
Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation
por: Fan, Yadong, et al.
Publicado: (2022) -
Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis
por: Tong, Yanli, et al.
Publicado: (2020) -
Comprehensive Analysis of Gut Microbiota and Fecal Bile Acid Profiles in Children With Biliary Atresia
por: Yang, Ting, et al.
Publicado: (2022)